Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review

BACKGROUND: Controversy exists about the incremental utility of nontraditional lipid biomarkers [e.g., apolipoprotein (apo) B, apo A-I, and non-HDL-C] in improving cardiovascular disease (CVD) risk prediction when added to a conventional model of traditional risk factors (e.g., total cholesterol, LD...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Appl Lab Med
मुख्य लेखकों: Sandhu, Paramjit K., Musaad, Salma M.A., Remaley, Alan T., Buehler, Stephanie S., Strider, Sonya, Derzon, James H., Vesper, Hubert W., Ranne, Anne, Shaw, Colleen S., Christenson, Robert H.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2016
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5103618/
https://ncbi.nlm.nih.gov/pubmed/27840858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1373/jalm.2016.021006
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन